Integrative therapies for cancer symptom relief
Examining the Impact of an Integrative Oncology Program on Patient Symptoms and Quality of Life: a Prospective Pragmatic Registry Protocol Study
This study is testing whether acupuncture or touch therapies can help relieve symptoms and improve the quality of life for cancer patients undergoing treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 750 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Shaare Zedek Medical Center Academic / other |
| Locations | 1 site (Jerusalem) |
| Trial ID | NCT04940780 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of complementary and integrative medicine (CIM) on patients experiencing symptoms related to cancer and its treatment. A total of 750 patients undergoing active oncology treatment will receive a consultation with an integrative oncologist followed by eight sessions of either acupuncture or touch therapies. The aim is to assess the impact of these therapies on symptom burden, quality of life, and overall function. The study will provide valuable insights into the role of CIM in supportive cancer care.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are currently undergoing active oncology treatment.
Not a fit: Patients who are not interested in attending all eight CIM treatment sessions or do not meet the eligibility criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life for cancer patients by alleviating their symptoms through integrative therapies.
How similar studies have performed: Previous studies have shown positive outcomes with similar integrative approaches in oncology, indicating a promising avenue for symptom management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age ≥ 18 years * undergoing active oncology treatment * fully understand the study plan * agree to sign the study informed consent form. Exclusion Criteria: * not fulfilling all of the study criteria * not interested in attending all 8 weekly CIM treatments sessions
Where this trial is running
Jerusalem
- Institute of Oncology, Shaare Zedek Medical Center — Jerusalem, Israel (Recruiting)
Study contacts
- Study coordinator: Noah Samuels, M.D.
- Email: noahs@szmc.org.il
- Phone: 972-26666395
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.